2008 North American Medical Imaging Product Innovation of the Year Award.
Burbank, CA (PRWEB) March 19, 2008
Imaging3(TM), Inc. (OTC BB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that the company has been awarded the Frost & Sullivan "2008 North American Medical Imaging Product Innovation of the Year Award."
The company's patented Dominion Volumetric Imaging Scanner was recognized for its breakthrough technology which will revolutionize how medical imaging is used for both diagnostic and interventional procedures. Chairman and CEO of Imaging3 Dean Janes stated in his acceptance speech, "We are honored to be recognized and have our technology validated by such a prestigious company as Frost & Sullivan." The awards ceremony was held in San Francisco on Wednesday, March 12th 2008 at the Hyatt Regency in Fisherman's Wharf. In attendance from Imaging3 were Dean Janes, Chairman and CEO, Chris Sohn, President and COO, Xavier Aguilera, CFO and Mike Nessen, Vice President of Business Development.
Mr. Janes also stated, "We are proud to be included with long time industry innovators such as Siemens, Phillips, and Boston Scientific Corp. who were also in attendance and honored in this year's Frost & Sullivan awards ceremony. We will proudly display this award in our office for all of our employees and visitors to see."
Frost & Sullivan recognizes companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. The Frost & Sullivan Industry analyst team tracks all new product launches, product differentiation strategies, Research and Development spending, products in development, and new product features and modifications. This is accomplished through interviews with the market participants and extensive primary technology research.
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at Imaging3, Inc. for more information.
Safe Harbor Statement:
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive, and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.